MNDA and MAGEB4 (- methylation) are myeloid cell differentiation antigen involved in chronic lymphocytic leukemia and other cancers [60] and cancer-testis antigens associated with immunotherapy treatment responses and undergoing aberrant methylation [61,62]. Here, MNDA is linked to cancer.